Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.2.0.727
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Contract Research Revenue $ 77,000 $ 0 $ 134,636 $ 0
OPERATING EXPENSES        
Research and development 1,354,728 1,118,251 2,803,141 2,192,031
General and administrative 1,124,066 1,302,236 2,301,907 2,357,483
Total Operating Expenses 2,478,794 2,420,487 5,105,048 4,549,514
Loss from Operations (2,401,794) (2,420,487) (4,970,412) (4,549,514)
Other expense, net 2,738 5,385 4,231 15,381
NET LOSS $ (2,404,532) $ (2,425,872) $ (4,974,643) $ (4,564,895)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share) $ (0.04) $ (0.08) $ (0.11) $ (0.14)
WEIGHTED AVERAGE BASIC AND DILUTED NUMBER OF SHARES OUTSTANDING (in shares) 55,942,013 32,000,000 45,815,657 32,000,000